Searched for
DRUGMAKER MODERNA INC
Pfizer's $11.6 bn Biohaven buy could spark more biotech dealsThe deal, announced on Tuesday, is the biggest in the sector so far this year and ends a dearth of large acquisitions, which along with cli...- Novavax says COVID vaccine triggers immune response to Omicron variantNovavax's two-dose, protein-based vaccine was authorized for use this week by European Union regulators and the World Health Organization.
- Moderna lowers forecast for 2021 COVID-19 vaccine deliveriesThe drugmaker said Thursday that longer delivery lead times for exports and a temporary impact from expanding its fill-finish capacity may ...
- Moderna working on booster to combine COVID-19 vaccine with a flu shotFlu shots cost around $18 to $25 a dose, according to U.S. government data and competition has kept price increases in check, with producer...
- Moderna files for U.S. authorization to use its COVID-19 vaccine in teensModerna Inc said on Thursday it has filed for U.S. authorities to use its COVID-19 vaccine in adolescents aged 12 through 17, potentially o...
- South Korea approves Moderna's COVID-19 vaccineThe green light comes after two of three expert panels recommended approval be granted for the two-dose vaccine based on safety and efficac...
- Moderna boosting COVID-19 vaccine-making capacity, targets up to 3 billion shots in 2022"As we look forward to next year, we just see so much need for primary vaccine, we are hearing it all over the world, and also boosters," M...
- Pfizer wants to make vaccine in India if faster clearance, export freedom assured: SourcesThe U.S. company pulled an application last month seeking emergency approval for its product in India after the drug regulator declined its...
- EU agency ponders approval for Moderna's COVID-19 vaccineThe meeting of the European Medicines Agency's human medicines committee (CHMP) comes amid high rates of infections in many EU countries an...
- Israel's health ministry authorizes use of Moderna's COVID-19 vaccineModerna has received authorization for its COVID-19 vaccine in the United States and Canada and additional authorizations are currently und...
- Qatar, Oman to receive Pfizer-BioNTech COVID-19 vaccine this weekA ministry statement said people aged 16 years and above would be eligible. Qatar has also signed an agreement with drugmaker Moderna Inc t...
- J&J enrolls about 45,000 participants for late-stage COVID-19 vaccine trialJ&J also said it plans to submit an emergency use authorization application to the U.S. Food and Drug Administration (FDA) in February if t...
- Moderna to supply up to 125 mn COVID-19 vaccine doses globally in first quarterThe company said 85 million to 100 million of those doses would be available in the United States, with 15 million to 25 million available ...
- Major Gulf stock markets gain on vaccine optimism; Saudi Arabia shares easeDubai's main share index advanced more than a percent, with the emirate's largest lender Emirates NBD adding 1.5%, while real estate firm E...
- Pfizer set to start coronavirus immunization pilot program in four American statesThe four states – Rhode Island, Texas, New Mexico, and Tennessee – were selected for the program because of their differences in overall si...
- Moderna says preparing for launch of coronavirus vaccine candidateWhile the company did not give a clear timeline on the release of data from these trials on Thursday, it has said that early data is expect...
- U.S. inks $1.5 billion deal with Moderna for 100 million doses of COVID-19 vaccineThe United States in recent weeks has made deals to acquire hundreds of millions of doses of potential COVID-19 vaccines from several compa...
- Moderna COVID-19 vaccine could be ready for use by end of year, US saysThe trial is the first such late-stage study under the Trump administration's program to speed development of measures against the novel co...
- Rupee opens 14 paise up at 75.77 against dollar“Rupee is expected quote in the range of 75.20 and 76.20,” brokerage Motilal Oswal Financial Services said in a report.
- Pfizer, BioNTech to co-develop potential coronavirus vaccineThe drugmakers will start the collaboration immediately and have signed a letter of intent for the vaccine's distribution outside China, th...
Load More
